Yolanda Juarez-Luna challenges the sentence imposed following the revocation of her probation. She argues that a spe *347 cial condition of supervised release included in her written judgment conflicts with the district court’s oral pronouncement of sentence. Specifically, at the revocation hearing, the district court ordered various conditions of supervised release, including Juarez-Luna’s participation in a “program approved by the United States Probation Office for the treatment of narcotic, drug, or alcohol dependency.” In the written judgment, however, the court included an additional drug testing requirement associated with this condition. Juarez-Luna contends that the conflict between the written judgment and oral pronouncement warrants remand.

Because Juarez-Luna had no opportunity to object to the written judgment in the district court, we review the court’s sentencing decision for abuse of discretion. United States v. Vega, 332 F.3d 849, 851 n. 1 (5th Cir. 2003). “[A] defendant has a constitutional right to be present at sentencing.” Id. at 852. Accordingly, if the written judgment conflicts with the oral pronouncement of sentence, the oral pronouncement controls. Id. If, however, the difference between the written judgment and oral pronouncement creates merely an ambiguity, we “look to the intent of the sentencing court, as evidenced in the record to determine the defendant’s sentence.” United States v. Torres-Aguilar, 352 F.3d 934, 935 (5th Cir. 2003) (internal quotation marks and citation omitted).

The written judgment reflects that drug testing is both a special and a mandatory condition of supervised release. Thus, the district court’s inclusion of a drug testing component, as part of the special condition of supervised release requiring substance abuse treatment, does not broaden the restrictions or responsibilities of Juarez-Luna’s supervised release. See United States v. Mireles, 471 F.3d 551, 558 (5th Cir. 2006); Vega, 332 F.3d at 852-54. Accordingly, there is no conflict warranting remand. See Mireles, 471 F.3d at 558; Vega, 332 F.3d at 852-54

AFFIRMED.